Neonatology Now

In this episode, we talk with Professor Julia Bielicki, a leading expert in pediatric infectious diseases, about how to optimize antibiotic use in neonatology. She discusses why antibiotic overuse remains a global concern, the differences in prescribing practices across countries, and how evidence‑based strategies can ensure better, more targeted therapy for newborns. We also explore innovative clinical trial approaches, effective infection prevention measures such as maternal breast milk, probiotics, and kangaroo care, and how building a culture of mindful antibiotic stewardship can improve neonatal outcomes. Don't miss this exciting opportunity to stay at the forefront of neonatal care advancements!

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the August episode of the Neonatology Now podcast, join your host, Prof Dr Mario Rüdiger, in an engaging conversation with the esteemed guest, Dr Nadya Yousef. Together, they discuss the evolution of lung ultrasound from a niche technique to a standard of care, its dual role as a diagnostic and functional tool in neonatal respiratory management, the limitations of traditional scoring systems, the move toward simplified approaches and the emerging role of artificial intelligence in ultrasound interpretation and decision-making.

Tune in to hear what Dr Yousef recommends for training and competency in neonatal lung ultrasound and common pitfalls in clinical practice and practical tips for everyday use in the NICU.

Dr. Yousef also shares personal insights from her career, her vision for future research, and advice for young clinicians balancing clinical work and academic development.

Interested in learning more?

neoGEPP

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In this episode of Neonatology Now, host Mario Rüdiger speaks with Prof Eric Peebles about the evolving understanding and management of neonatal encephalopathy. They trace the history of treating hypoxic‑ischemic encephalopathy (HIE) and discuss how hypothermic therapy became an evidence-based standard. The conversation highlights the urgent need for global harmonization of neonatal data, as shown by striking inconsistencies across international registries.Prof Peebles explains how the Newborn Brain Society used a modified Delphi process with experts from 81 countries—including parent advocates—to define Core Data Elements (CDEs) that support consistent research and equitable participation worldwide. The episode also explores how digital tools and automated data extraction will shape the future of neonatal research and improve long-term, family-centered outcomes.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the June episode, Dr. Rachel Greenberg discusses the challenges of off-label drug use in neonatology, focusing on the case of diazoxide for treating hypoglycemia in newborns. We explore why so many medications are prescribed beyond their approved indications, the ethical and pharmacological complexities involved, and how clinical use of diazoxide has evolved over time. Dr. Greenberg shares her research insights and highlights the urgent need for standardized guidelines and pediatric-specific studies to ensure safe and effective care for our youngest patients. Don't miss this exciting opportunity to stay at the forefront of neonatal care advancements!

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the May episode of Neonatology Now, we explore the Master of Advanced Studies in Neonatology by the European School of Neonatology. We speak with students about their personal perspectives, what motivated them to join the program, and how they experience this international and competency-based form of training. Their insights highlight the value of exchanging ideas across borders, learning from different clinical approaches, and bringing new perspectives into neonatal care.

Interested in learning more? Explore the MAS Studies:

Master of Advanced Studies (MAS) in Neonatology

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In this episode, we talk with Professor Nicholas Embleton, a leading authority in neonatal nutrition, about the evolution of parenteral nutrition and its transformative role in the care of preterm infants. He traces the history of neonatal nutrition from its early experimental use in the 1970s to its central role in today’s neonatal intensive care. Professor Ambleton shares key milestones in understanding amino acid balance, the shift from focusing solely on survival to optimizing long-term outcomes, and the essential role of clinical governance in ensuring safe and effective delivery of nutrition. We also explore current challenges, including the need for real-time nutritional monitoring to better tailor care for vulnerable neonates.

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In this episode of Neonatology Now, join your host, Prof Dr Mario Rüdiger, in an engaging conversation with the esteemed guests, Professor Deirdre Murray and Professor Luigi Titomanlio about how European paediatric and neonatal research come together at the Congress of the European Paediatric Academic Societies (CEPAS) 2026 in Lyon. The conversation explores the roles of the European Academy of Paediatrics (EAP) and the European Society for Paediatric Research (ESPR) in shaping everyday paediatric and neonatal practice, advancing cross-border research, and setting scientific priorities for the future. Deirdre and Luigi highlight what makes CEPAS 2026 unique: its new congress format, strong focus on neonatology, integration of family-centred advocacy through the Global Foundation for the Care of Newborn Infants, and its many opportunities for trainees and early-career researchers. The episode closes with their personal messages to young clinicians and scientists, sharing what gives them optimism about the future of paediatrics and neonatology in Europe and why Lyon 2026 is a meeting not to be missed. Don't miss this exciting opportunity to stay at the forefront of neonatal care advancements!

Register now for CEPAS

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the February episode of the Neonatology Now podcast, join your host, Prof Dr Mario Rüdiger, in an engaging conversation with the esteemed guest, Dr Roger Soll. Together, they discuss evolving survival rates among extremely preterm infants and what these trends mean for neonatal care. They trace the remarkable progress since the 1980s—driven by innovations like surfactant therapy and non‑invasive ventilation—while examining why recent gains in survival have slowed. The conversation explores ethical dilemmas in caring for babies born at 22–24 weeks, the importance of including family perspectives in outcome assessments, and the future possibilities of neonatal innovation, including artificial womb technology.

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the January episode of the Neonatology Now podcast, join your host, Prof Dr Mario Rüdiger, in an engaging conversation with the esteemed guest, Prof Daniele De Luca. Together, they discuss his recent contributions to The Lancet Child & Adolescent Health Commission on the Future of Neonatology. Tune in to hear what Prof De Luca thinks why neonatal research and development have lagged so far behind other medical specialties and where he sees the most promising intersections for future neonatal innovation.

Interested in learning more? Explore the following recommended literature by Prof De Luca.

The Lancet Child & Adolescent Health Commission on the future of neonatology

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.

In the December episode of the Neonatology Now podcast, join your host, Prof Dr Mario Rüdiger, in an engaging conversation with the esteemed guest, Dr Prakesh Shah. Together, they discuss his landmark study “Outcomes of Preterm Infants Born at 22 to 23 Weeks’ Gestation in 11 International Neonatal Networks”. Tune in to hear what Dr Shah tells us about evaluated survival, major morbidities, and international practice variations for over 5,000 infants cared for in 11 networks across 12 countries.

Interested in learning more? Explore the following recommended literature by Dr Prakesh Shah:

The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities

Outcomes of Preterm Infants Born at 22 to 23 Weeks’ Gestation in 11 International Neonatal Networks

About the host: Mario Rüdiger underwent Neonatology training at the Charite Hospital in Berlin, gained professional experience in Innsbruck, Austria, and presently holds the position of Director at the Saxony Center for Feto/Neonatal Health. Additionally, he serves as the Chair of the Department of Neonatology and Pediatric Intensive Care Medicine at the University Hospital Dresden. Rüdiger is an active member of the neonatal task force of ILCOR and currently serves as the President of the German Society of Perinatal Medicine. His primary focus lies in delivery room management and cellular therapies.

Thank you for tuning in! We value your input. If you have any suggestions, feedback, topic ideas, or comments, feel free to reach out to us at [email protected]. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ The podcast is intended exclusively for neutral information, training and entertainment. It is not a substitute for professional advice from a doctor or pharmacist and must not be used as a basis for independent diagnosis and starting, changing or stopping treatment of illnesses. The content of this podcast reflects the personal opinion of the presenter and his guests. The presenters take great care to present the current state of knowledge. Like any other science, neonatology is subject to constant developments. Subject to change without notice.